Moving forward in safety: Grifols introduces a holographic seal on its plasma derivative packaging.


16.03.2010

Our plasma derivatives production facilities have started the introduction of the holographic seal on the packaging flaps which will be placed on all our plasma derivatives from now on. This seal incorporates state-of-the-art technology to offer health professionals and patients the highest guarantee on the authenticity of Grifols products.

Grifols has a commitment that goes beyond the measures adopted to certify the quality and safety of the plasma used in the manufacture of plasma derivatives by using the latest technologies in their production processes. The holographic seal together with the laser marking of each vial of product or the flip-off capsule are safety measures designed to ensure trust in Grifols plasma derivatives.